Trial Outcomes & Findings for A Comparison of 5 Low Volume Bowel Preparations (NCT NCT01719653)
NCT ID: NCT01719653
Last Updated: 2017-03-24
Results Overview
The quality of the colon preparation as graded using our new Chicago Bowel Preparation Scale (BPS) (Adventist Midwest Region Institutional Review Board, AMH 2010-01-80; ClinicalTrials.gov NCT01063049). Chicago BPS total score is ranges from 0 (very poor) to 36 (outstanding). Modified Chicago BPS total score is ranges from 0 (very poor) to 33 (outstanding). Chicago BPS Fluid score is ranges from 0 (dry) to 3 (wet).
COMPLETED
PHASE4
1079 participants
At completion of colonoscopy - day 1
2017-03-24
Participant Flow
Participant milestones
| Measure |
MiraLAX 306 g (Day-Prior)
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 51 g at 12 noon; Gatorade 64 oz mixed with Miralax 255 g from about 6 PM to 9 PM
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MiraLAX 357 g (Day-Prior)
MiraLAX 357 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 68 g at 12 noon; Gatorade 64 oz mixed with Miralax 289 g from about 6 PM to 9 PM.
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MiraLAX 306 g (Split-Dose)
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed as a split-dose as follows: Gatorade 32oz mixed with Miralax 153 g from about 6 PM to 8 PM the day prior to the colonoscopy; Gatorade 32oz mixed with Miralax 153 g from about 2-4 hours prior to the colonoscopy.
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MoviPrep (Split-Dose)
MoviPrep consumed as a split-dose as follows: MoviPrep 1 liter consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 0.5 liter of clear liquids; MoviPrep 1 liter consumed from 3-4 hours prior to the colonoscopy followed by 0.5 liter of clear liquids.
MoviPrep: MoviPrep consumed as described in each arm.
|
SUPREP (Split-Dose)
SUPREP consumed as a split-dose as follows: SUPREP 16 oz consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 32 oz of clear liquids; SUPREP 16 oz consumed from 3-4 hours prior to the colonoscopy followed by 32 oz of clear liquids.
SUPREP: SUPREP consumed as described in each arm.
|
|---|---|---|---|---|---|
|
Overall Study
STARTED
|
209
|
213
|
218
|
218
|
221
|
|
Overall Study
COMPLETED
|
200
|
200
|
200
|
200
|
200
|
|
Overall Study
NOT COMPLETED
|
9
|
13
|
18
|
18
|
21
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
A Comparison of 5 Low Volume Bowel Preparations
Baseline characteristics by cohort
| Measure |
MiraLAX 306 g (Day-Prior)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 51 g at 12 noon; Gatorade 64 oz mixed with Miralax 255 g from about 6 PM to 9 PM
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MiraLAX 357 g (Day-Prior)
n=200 Participants
MiraLAX 357 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 68 g at 12 noon; Gatorade 64 oz mixed with Miralax 289 g from about 6 PM to 9 PM.
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MiraLAX 306 g (Split-Dose)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed as a split-dose as follows: Gatorade 32oz mixed with Miralax 153 g from about 6 PM to 8 PM the day prior to the colonoscopy; Gatorade 32oz mixed with Miralax 153 g from about 2-4 hours prior to the colonoscopy.
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MoviPrep (Split-Dose)
n=200 Participants
MoviPrep consumed as a split-dose as follows: MoviPrep 1 liter consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 0.5 liter of clear liquids; MoviPrep 1 liter consumed from 3-4 hours prior to the colonoscopy followed by 0.5 liter of clear liquids.
MoviPrep: MoviPrep consumed as described in each arm.
|
SUPREP (Split-Dose)
n=200 Participants
SUPREP consumed as a split-dose as follows: SUPREP 16 oz consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 32 oz of clear liquids; SUPREP 16 oz consumed from 3-4 hours prior to the colonoscopy followed by 32 oz of clear liquids.
SUPREP: SUPREP consumed as described in each arm.
|
Total
n=1000 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|
|
Age, Continuous
|
60.9 years
STANDARD_DEVIATION 12.7 • n=5 Participants
|
61.3 years
STANDARD_DEVIATION 12.4 • n=7 Participants
|
59.1 years
STANDARD_DEVIATION 11.3 • n=5 Participants
|
60.1 years
STANDARD_DEVIATION 11.4 • n=4 Participants
|
60.6 years
STANDARD_DEVIATION 11.2 • n=21 Participants
|
60.4 years
STANDARD_DEVIATION 11.8 • n=10 Participants
|
|
Sex: Female, Male
Female
|
99 Participants
n=5 Participants
|
99 Participants
n=7 Participants
|
101 Participants
n=5 Participants
|
97 Participants
n=4 Participants
|
99 Participants
n=21 Participants
|
495 Participants
n=10 Participants
|
|
Sex: Female, Male
Male
|
101 Participants
n=5 Participants
|
101 Participants
n=7 Participants
|
99 Participants
n=5 Participants
|
103 Participants
n=4 Participants
|
101 Participants
n=21 Participants
|
505 Participants
n=10 Participants
|
|
Region of Enrollment
United States
|
200 participants
n=5 Participants
|
200 participants
n=7 Participants
|
200 participants
n=5 Participants
|
200 participants
n=4 Participants
|
200 participants
n=21 Participants
|
1000 participants
n=10 Participants
|
PRIMARY outcome
Timeframe: At completion of colonoscopy - day 1The quality of the colon preparation as graded using our new Chicago Bowel Preparation Scale (BPS) (Adventist Midwest Region Institutional Review Board, AMH 2010-01-80; ClinicalTrials.gov NCT01063049). Chicago BPS total score is ranges from 0 (very poor) to 36 (outstanding). Modified Chicago BPS total score is ranges from 0 (very poor) to 33 (outstanding). Chicago BPS Fluid score is ranges from 0 (dry) to 3 (wet).
Outcome measures
| Measure |
MiraLAX 306 g (Day-Prior)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 51 g at 12 noon; Gatorade 64 oz mixed with Miralax 255 g from about 6 PM to 9 PM
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MiraLAX 357 g (Day-Prior)
n=200 Participants
MiraLAX 357 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 68 g at 12 noon; Gatorade 64 oz mixed with Miralax 289 g from about 6 PM to 9 PM.
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MiraLAX 306 g (Split-Dose)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed as a split-dose as follows: Gatorade 32oz mixed with Miralax 153 g from about 6 PM to 8 PM the day prior to the colonoscopy; Gatorade 32oz mixed with Miralax 153 g from about 2-4 hours prior to the colonoscopy.
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MoviPrep (Split-Dose)
n=200 Participants
MoviPrep consumed as a split-dose as follows: MoviPrep 1 liter consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 0.5 liter of clear liquids; MoviPrep 1 liter consumed from 3-4 hours prior to the colonoscopy followed by 0.5 liter of clear liquids.
MoviPrep: MoviPrep consumed as described in each arm.
|
SUPREP (Split-Dose)
n=200 Participants
SUPREP consumed as a split-dose as follows: SUPREP 16 oz consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 32 oz of clear liquids; SUPREP 16 oz consumed from 3-4 hours prior to the colonoscopy followed by 32 oz of clear liquids.
SUPREP: SUPREP consumed as described in each arm.
|
|---|---|---|---|---|---|
|
Chicago Bowel Preparation Scale
Chicago BPS Total Score
|
33.54 units on a scale
Standard Deviation 4.28
|
34.00 units on a scale
Standard Deviation 4.25
|
34.67 units on a scale
Standard Deviation 3.58
|
34.95 units on a scale
Standard Deviation 3.39
|
35.16 units on a scale
Standard Deviation 2.34
|
|
Chicago Bowel Preparation Scale
Modified Chicago BPS Total Score
|
31.82 units on a scale
Standard Deviation 3.59
|
32.14 units on a scale
Standard Deviation 3.69
|
32.33 units on a scale
Standard Deviation 2.93
|
32.54 units on a scale
Standard Deviation 2.92
|
32.65 units on a scale
Standard Deviation 1.72
|
|
Chicago Bowel Preparation Scale
Chicago BPS Fluid Score
|
0.90 units on a scale
Standard Deviation 0.83
|
1.03 units on a scale
Standard Deviation 0.89
|
1.84 units on a scale
Standard Deviation 0.90
|
1.45 units on a scale
Standard Deviation 0.82
|
1.30 units on a scale
Standard Deviation 0.91
|
SECONDARY outcome
Timeframe: At completion of colonoscopy - day 1The quality of the colon preparation as graded using Boston Bowel Preparation total scores is range from 0 (very poor) to 9 (outstanding).
Outcome measures
| Measure |
MiraLAX 306 g (Day-Prior)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 51 g at 12 noon; Gatorade 64 oz mixed with Miralax 255 g from about 6 PM to 9 PM
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MiraLAX 357 g (Day-Prior)
n=200 Participants
MiraLAX 357 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 68 g at 12 noon; Gatorade 64 oz mixed with Miralax 289 g from about 6 PM to 9 PM.
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MiraLAX 306 g (Split-Dose)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed as a split-dose as follows: Gatorade 32oz mixed with Miralax 153 g from about 6 PM to 8 PM the day prior to the colonoscopy; Gatorade 32oz mixed with Miralax 153 g from about 2-4 hours prior to the colonoscopy.
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MoviPrep (Split-Dose)
n=200 Participants
MoviPrep consumed as a split-dose as follows: MoviPrep 1 liter consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 0.5 liter of clear liquids; MoviPrep 1 liter consumed from 3-4 hours prior to the colonoscopy followed by 0.5 liter of clear liquids.
MoviPrep: MoviPrep consumed as described in each arm.
|
SUPREP (Split-Dose)
n=200 Participants
SUPREP consumed as a split-dose as follows: SUPREP 16 oz consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 32 oz of clear liquids; SUPREP 16 oz consumed from 3-4 hours prior to the colonoscopy followed by 32 oz of clear liquids.
SUPREP: SUPREP consumed as described in each arm.
|
|---|---|---|---|---|---|
|
Boston Bowel Preparation Scale
|
8.39 units on a scale
Standard Deviation 1.36
|
8.57 units on a scale
Standard Deviation 1.16
|
8.66 units on a scale
Standard Deviation 1.16
|
8.80 units on a scale
Standard Deviation 1.04
|
8.80 units on a scale
Standard Deviation 0.77
|
SECONDARY outcome
Timeframe: At completion of colonoscopy - day 1The cleanliness of the colon as rated by the gastroenterologist using an adequate/inadequate scale where an adequate preparation is defined as being able to see at least 95% of the mucosa of the colon after washing and suctioning; otherwise, the preparation is rated as inadequate.
Outcome measures
| Measure |
MiraLAX 306 g (Day-Prior)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 51 g at 12 noon; Gatorade 64 oz mixed with Miralax 255 g from about 6 PM to 9 PM
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MiraLAX 357 g (Day-Prior)
n=200 Participants
MiraLAX 357 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 68 g at 12 noon; Gatorade 64 oz mixed with Miralax 289 g from about 6 PM to 9 PM.
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MiraLAX 306 g (Split-Dose)
n=200 Participants
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed as a split-dose as follows: Gatorade 32oz mixed with Miralax 153 g from about 6 PM to 8 PM the day prior to the colonoscopy; Gatorade 32oz mixed with Miralax 153 g from about 2-4 hours prior to the colonoscopy.
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MoviPrep (Split-Dose)
n=200 Participants
MoviPrep consumed as a split-dose as follows: MoviPrep 1 liter consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 0.5 liter of clear liquids; MoviPrep 1 liter consumed from 3-4 hours prior to the colonoscopy followed by 0.5 liter of clear liquids.
MoviPrep: MoviPrep consumed as described in each arm.
|
SUPREP (Split-Dose)
n=200 Participants
SUPREP consumed as a split-dose as follows: SUPREP 16 oz consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 32 oz of clear liquids; SUPREP 16 oz consumed from 3-4 hours prior to the colonoscopy followed by 32 oz of clear liquids.
SUPREP: SUPREP consumed as described in each arm.
|
|---|---|---|---|---|---|
|
Adequate/Inadequate Scale
Adequate
|
195 Participants
|
196 Participants
|
198 Participants
|
197 Participants
|
197 Participants
|
|
Adequate/Inadequate Scale
Inadequate
|
5 Participants
|
4 Participants
|
2 Participants
|
3 Participants
|
3 Participants
|
Adverse Events
MiraLAX 306 g (Day-Prior)
MiraLAX 357 g (Day-Prior)
MiraLAX 306 g (Split-Dose)
MoviPrep (Split-Dose)
SUPREP (Split-Dose)
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
MiraLAX 306 g (Day-Prior)
n=200 participants at risk
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 51 g at 12 noon; Gatorade 64 oz mixed with Miralax 255 g from about 6 PM to 9 PM
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MiraLAX 357 g (Day-Prior)
n=200 participants at risk
MiraLAX 357 g and Gatorade 64 oz (1/2 gallon) consumed the day-prior to the colonoscopy as follows: Miralax 68 g at 12 noon; Gatorade 64 oz mixed with Miralax 289 g from about 6 PM to 9 PM.
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MiraLAX 306 g (Split-Dose)
n=200 participants at risk
MiraLAX 306 g and Gatorade 64 oz (1/2 gallon) consumed as a split-dose as follows: Gatorade 32oz mixed with Miralax 153 g from about 6 PM to 8 PM the day prior to the colonoscopy; Gatorade 32oz mixed with Miralax 153 g from about 2-4 hours prior to the colonoscopy.
MiraLAX: MiraLAX consumed as described in each arm.
Gatorade: Gatorade consumed as described in each arm.
|
MoviPrep (Split-Dose)
n=200 participants at risk
MoviPrep consumed as a split-dose as follows: MoviPrep 1 liter consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 0.5 liter of clear liquids; MoviPrep 1 liter consumed from 3-4 hours prior to the colonoscopy followed by 0.5 liter of clear liquids.
MoviPrep: MoviPrep consumed as described in each arm.
|
SUPREP (Split-Dose)
n=200 participants at risk
SUPREP consumed as a split-dose as follows: SUPREP 16 oz consumed from about 6 PM to 7 PM the day prior to the colonoscopy followed by 32 oz of clear liquids; SUPREP 16 oz consumed from 3-4 hours prior to the colonoscopy followed by 32 oz of clear liquids.
SUPREP: SUPREP consumed as described in each arm.
|
|---|---|---|---|---|---|
|
Gastrointestinal disorders
Nausea
|
32.5%
65/200
|
40.0%
80/200
|
33.0%
66/200
|
32.5%
65/200
|
35.0%
70/200
|
|
Gastrointestinal disorders
Vomiting
|
9.0%
18/200
|
11.5%
23/200
|
6.0%
12/200
|
4.0%
8/200
|
6.5%
13/200
|
|
Gastrointestinal disorders
Abdominal Cramps/Pain
|
33.0%
66/200
|
35.0%
70/200
|
34.0%
68/200
|
37.5%
75/200
|
39.0%
78/200
|
|
Gastrointestinal disorders
Bloating
|
59.5%
119/200
|
61.0%
122/200
|
63.0%
126/200
|
55.0%
110/200
|
55.5%
111/200
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place